Aims We wanted to study the effects of a 600 mg inhaled salbutamol dose on the cardiovascular and respiratory autonomic nervous regulation in eight children suffering from bronchial asthma. Methods In this randomized, double-blind, placebo-controlled, crossover study we continuously measured electrocardiogram, finger systolic arterial pressure (SAP) and flow-volume spirometry at baseline as well as 20 min and 2 h after the drug inhalation. The R-R interval (the time between successive heart beats) and SAP variabilities were assessed by using spectral analysis. Baroreflex sensitivity was assessed by using cross-spectral analysis. Results Salbutamol significantly decreased the total and low frequency (LF) variability of R-R intervals as well as the high frequency (HF) variability of R-R intervals and of SAP. Salbutamol significantly increased the LF/HF ratio of R-R intervals and of SAP, minute ventilation, heart rate and forced pulmonary function in comparison with placebo. The weight of the subjects significantly correlated positively with baroreflex sensitivity and negatively with heart rate after the salbutamol inhalation. Conclusions We conclude that the acute salbutamol inhalation decreases cardiovagal nervous responsiveness, increases sympathetic dominance in the cardiovascular autonomic balance, and has a tendency to decrease baroreflex sensitivity in addition to improved pulmonary function.
as drug treatment affect the sympathetic and parasympathetic Introduction control of cardiorespiratory organ functions [4] [5] [6] [7] [8] [9] [10] [11] . Therefore, we investigated how the acute administration of Salbutamol, a selective b-adrenoceptor agonist is used widely as a bronchodilator in the treatment of asthma and other salbutamol affects the cardiorespiratory autonomic regulation of prepubertal children suffering from bronchial asthma. reversible obstructive airway diseases. The adverse effects, which are quite rare after an administration by inhalation, are primarily due to the activated cardiovascular, neuronal Methods and metabolic b-adrenoceptors caused by the drug absorption into the systemic circulation [1] . Thus, the principal adverse Study subjects effects include tachycardia, palpitation, tremor, peripheral Eight children with diagnosed bronchial asthma [five males vasodilatation, hyperactivity and various metabolic effects. and three females, mean age (s.d.) 10.5 (0.8) years, height The association between the use of b 2 -adrenoceptor agonists 143 (8) cm, weight 39 (9) kg] participated in the study after and the increased risk of fatal or near fatal asthma is a written informed consent was obtained from their parents. controversial [2, 3] . All these findings suggest that b 2 -
The similar demography diminishes the physiological variadrenoceptor agonists may markedly interfere with cardiovasation caused e.g. by age [12] [13] [14] or obesity [13] . Sex has cular and respiratory autonomic nervous regulation. The been reported to be unimportant in this context [14] . Before effects of stable bronchial asthma on cardiovascular autocommencing the study each subject was physically examined. nomic regulation is negligible in children [4] .
Children with diabetes mellitus, cardiovascular, gastrointestiTo our knowledge there are no reports published about nal, urinary tract, central or peripheral nervous system the acute effects of b 2 -adrenoceptor agonist medication on disease were excluded from the study. the beat-to-beat variability of R-R intervals, oscillations of The children were recruited from the paediatric asthma blood pressure or baroreflex sensitivity. These measures have register of Turku University Hospital. Asthma was diagnosed been proven to be valuable in the studies how various on the basis of a clinical history and verified intermittent, neurological, respiratory and cardiovascular diseases, as well reversible airway obstruction. Pulmonary function (miniWright peak flow meter, Clement Clarke International Ltd, England), symptoms and medication were monitored daily following measurements at both cardiopulmonary test visits. 4. A 5 min study in upright position during fixed respirfor a 1-week period prior to the tests. Only children with stable asthma [the peak expiratory flow variability ratio, atory rate was done after standing up and stabilization of haemodynamics. (evening value-morning value)/evening value ×100%, was <20% during the observation period] were included in the A continuous precordial three channel electrocardiogram was obtained via a cardioscope (Olli Monitor 432, Kone study to avoid confusion produced by acute phase of the disease [11] . In addition, the subjects had not taken any b 2 -Instrument Division, Finland). A continuous noninvasive arterial blood pressure signal was recorded from the left adrenoceptor agonists regularly for 4 weeks, and the children were without any sympathomimetic medication for 4 days middle finger kept at heart level using an Ohmeda 2300 BP Monitor (Ohmeda, Inc., U.S.A.). A flow-volume spiprior to the tests. Five children regularly received inhaled corticosteroids and two inhaled disodium cromoglygate.
rometer signal (M901, Medikro Oy, Finland) was recorded to calculate pulmonary air flow and volume changes. The None used oral b 2 -adrenoceptor agonists or theophylline. There was no tea, cola-drink or chocolate intake or heavy analogue outputs of the monitors were connected to an analogue interface (M9401 Transducer Interface, Medikro physical exercise 24 h prior to the study or heavy meal within 2 h and no coffee intake at all.
Oy, Finland) of an IBM PC/AT compatible microcomputer equipped with an extended cardiovascular autonomic function test software package (Cafts, Medikro Oy, Finland) Study design developed for computing heart rate, blood pressure, air flow and air volume variabilities. The signals were The study protocol was approved by the ethics committee of the Turku University Hospital. The study followed a analogue-to-digital converted with a temporal resolution of 200 Hz. The software package utilizes a modified algorithm randomized, double-blind, placebo-controlled crossover design. The subjects visited the laboratory three times: an for QRS detection followed by interpolation of R peaks by second order polynomial fitting [19] . The R-R intervals introductory visit to familiarize the volunteer with the test procedure, and two test visits with 1-week intervals. The were detected with a temporal resolution of 2 ms and then systolic, mean, diastolic arterial and pulse pressure were studies were done between 16.00h and 21.00h to avoid circadian variation of measured parameters [15] . 
Study drug
analysis. Blood pressure at the level of brachial artery was measured before each cardiovascular test (Sphyg-A 600 mg inhaled salbutamol dose (salbutamol aerosol, SalbuventA, Leiras, Finland) or a placebo dose ( placebo momanometer/printer BP-203 M II, Instrumentarium, Finland). aerosol, Leiras, Finland) was used in the study. The 600 mg dose was given by administering a 200 mg dose three times with 5 min intervals and utilising a spacer device (volume Analysis 270 ml, RondoA, Leiras, Finland) [16] . The subjects inhaled the drug slowly after full expiration and then hold breath R-R interval and finger systolic arterial pressure variability as well as tidal volume and minute ventilation were for 10 s [17] . The mouth was rinsed immediately after the inhalation to minimize the proportion of a swallowed drug computed from user-defined stationary data. Samples of 200 R-R intervals were selected because of the requirement of dose [18] . stationary signals and because some children had difficulties to stay still for a long time. The time series of R-R intervals Methods and SAP and air flow signal were subject to spectral analysis of signal variability. Fast Fourier transformation was used for We measured forced pulmonary function as well as continuous signals of electrocardiogram, finger systolic the spectral analysis. Total variabilities for the R-R interval vector and SAP signal were generated after linear detrending arterial pressure and flow-volume spirometry before as well as 20 min and 2 h after the study drug inhalation. Sample of the signals and the respective variability spectra were integrated over frequency in three frequency bands (very size, drug dose and observation time were based on the pilot study with overnight Holter monitoring (n=3). In the low frequency band <0.07 Hz, low frequency (LF) band from 0.07 Hz to 0.15 Hz and high frequency (HF) band present study subject rested on a bed in a supine position for 15 min to stabilize haemodynamics before the autonomic from 0.15 Hz to 0.50 Hz). Because the selected timeseries consisted 200 R-R intervals, very low frequency oscillations nervous system function tests. The tests were performed in the following order: 1. A 5 min recording at supine rest (<0.07 Hz) could not be properly analysed and were therefore excluded. Sympathovagal balance was assessed by during spontaneous breathing. 2. One minute deep breathing test at supine rest in which subject breathed six consecutive LF/HF ratio for the R-R interval and systolic arterial pressure (SAP) spectra. Baroreflex sensitivity was assessed deep breathing cycles of 10 s duration (5 s inspiration and 5 s expiration). 3. A 5 min study at supine rest was repeated utilising fast Fourier transformation-based cross-spectral analysis. The parameter was defined as the square root of using a controlled breathing rate (>0.20 Hz in all the subjects). This was defined on the basis of the average the ratio the total variability of R-R intervals/the total variability of SAP. The frequency bands chosen were those breathing frequency of the first study and paced using a sound signal given by a microcomputer sound generator.
in which SAP changes occur prior to R-R interval changes with a coherence coefficient >0.5 [20] . During the deep The fixed respiratory rate was kept constant in all the breathing test the minima and maxima of the R-R intervals The normal distribution of the variables was confirmed using Shapiro-Wilks' W test and homogeneity of variances were detected and the respective expiratory/inspiratory ratios were computed. The maximal tidal volumes of the using Levene's test. The differences between placebo and salbutamol treatments, carry-over effects, and period effects corresponding deep breathing cycles were also computed.
were analysed by t-test for independent samples [21] and the (Table 1) . Salbutamol increased the LF/HF ratio of R-R intervals from 0.74 ms 2 to 0.83 ms 2 (0.04 to 0.14) during correlations were calculated with Pearson product-moment correlation (Statistica for Windows, release 4.5, StatSoft Inc., fixed respiratory rate at supine rest (P<0.05, Figure 2 Baroreflex sensitivity beats min −1 to 101 beats min −1 (7 to 13) in standing position when compared with placebo treatment (salbutamol The baroreflex sensitivity had tendency to decrease after salbutamol in upright position (placebo vs salbutamol, vs placebo, P<0.001 for both, Table 1 ). The weight of the children correlated negatively with heart rate in upright 20 min measurements P=0.08 and 2 h measurements P= 0.09, Table 3 ). However, it was dependent on the weight position 20 min after the salbutamol inhalation (r=−0.84, P<0.01) and also at supine rest 2 h after the salbutamol of the children 20 min after the salbutamol inhalation in upright position (r=0.73, P<0.05). inhalation (r=−0.73, P<0.05).
The total variability of R-R intervals decreased from 4.02 ms 2 to 3.51 ms 2 (95% CI, −0.96 to −0.04) and the Pulmonary function and ventilation HF variability of R-R intervals from 3.87 ms 2 to 3.34 ms 2 (−0.99 to −0.07) after salbutamol during fixed respiratory Forced expiratory flow in 1 s increased from 89% predicted to 103% (95% CI, 6 to 22, P<0.01), peak expiratory flow rate at supine rest (salbutamol vs placebo, P<0.05 for both, Figure 2 ). In the upright position the drug inhalation from 82% to 92% (2 to 18, P<0.05), mean expiratory flow when 50% of the forced expiratory volume remained in the decreased the total variability of R-R intervals from 3.49 ms 2 to 3.29 ms 2 (−0.30 to −0.10, P<0.001) and the LF lung from 70% to 97% (10 to 44, P<0.01) and mean expiratory flow when 25% of the forced expiratory volume variability of R-R intervals from 2.77 ms 2 to 2.63 ms 2 (−0.27 to −0.01, P<0.05) 20 min after the inhalation remained in the lung from 54% to 84% (23 to 37, Table 1 The effect of inhaled salbutamol on heart rate and R-R interval variability.
Drug Baseline 20 min 2 h
Supine position Heart rate (beats min −1 ) S 7 5 ± 3 9 0 ± 4*** 85±4** P 7 2 ± 4 7 2 ± 4 7 6 ± 4
Expiratory/inspiratory ratio S 1.61±0.06 1.46±0.06 1.58±0.07 P 1.57±0.06 1.56±0.05 1.53±0.08
Upright position
Heart rate (beats min −1 ) S 9 3 ± 4 102±4** 101±4*** P 9 2 ± 5 9 0 ± 4 9 1 ± 4 P<0.0001) after the salbutamol inhalation ( Table 4 ). The markedly decreased the total and LF variability of R-R intervals as well as the HF variability of R-R intervals and average maximal tidal volume in the deep breathing test also increased from 70% of vital capacity to 83% (5 to 21) of SAP. The drug increased the LF/HF ratio of R-R intervals and of SAP. The weight of the subjects correlated after the drug administration ( P<0.01). Minute ventilation also increased from 10.1 l min −1 to 12.8 l min −1 (0 to 5) positively with baroreflex sensitivity and negatively with heart rate after the salbutamol inhalation. The effects on after salbutamol in the upright position during fixed respiratory rate (P<0.05). The other adverse effects of the pulmonary function and minute ventilation are wellknown [1, [22] [23] [24] . salbutamol treatment in our children were tremor, palpitation, cough, headache and peripheral vasodilatation, all of It was interesting to note that the acute salbutamol inhalation markedly decreased the total, and particularly the which were considered mild.
HF variability of R-R intervals. This attenuation of respiratory sinus arrhythmia evidences a vagal withdrawal Discussion [6, 7] . The rhythmical changes in the vagal activity have been suggested to be caused by the net effect of the central Our study demonstrated that a fairly large therapeutic single dose (600 mg ) of inhaled salbutamol has profound effects on integration of the afferent inflow from systemic arterial baroreceptors, low-pressure receptors in the heart and cardiovascular autonomic regulation in prepubertal children suffering from bronchial asthma. The analysis of heart rate possibly the strech receptors of the lung [25] . No doseresponse characteristics of the variability indices are yet and blood pressure oscillations showed that the treatment Table 2 The effect of inhaled salbutamol on the blood pressure at the level of brachial artery and on the finger systolic arterial pressure variability. available. However, we considered the effect marked because in the deep breathing test, also a test of vagal control, can be in part explained by the increased average maximal tidal it was also evident in the upright position which is physiologically characterized by a lower vagal and higher volume after the salbutamol inhalation. Increased tidal volume is known to increase heart rate variability [27] and sympathetic activity. The reduction in the HF variability of R-R intervals was likely to cause the simultaneous therefore counteracts the heart rate variability reducing influence of the b 2 -adrenoceptor agonist. The major diminution in the HF variability of SAP [6] . The decrease in the HF variability of SAP in our study cannot be salbutamol effects on the beat-to-beat cardiovascular regulation were shortlasting, and they had almost disappeared produced by a decrease in ventilatory activity [26] , since both tidal volume and minute ventilation increased after the two h after the drug inhalation. However, the drug effects on the sympathovagal balance lasted longer: a significant salbutamol inhalation. The decreased cardiovagal activity also primarily increased the sympathetic dominance in the effect could still be identified at the end of the study 2 h after the drug inhalation. cardiovascular autonomic balance analysed by the LF/HF ratios of R-R intervals and of SAP. The lack of differences
The arterial baroreflex is important in readjusting acute Table 4 The effect of inhaled salbutamol on pulmonary function.
Drug Baseline 20 min 2 h
Forced expiratory flow in 1 s (% predicted) S 91±4 103±5** 104±7* P 8 9 ± 2 8 9 ± 3 9 1 ± 3
Peak expiratory flow (% predicted) S 83±4 9 2 ± 6* 95±7* P 8 4 ± 4 8 2 ± 4 8 3 ± 4
Mean expiratory flow 50 (% predicted) S 73±6 9 7 ± 9** 97±12** P 7 0 ± 4 7 0 ± 6 6 9 ± 4
Mean expiratory flow 25 (% predicted) S 54±8 7 6 ± 12* 84±7**** P 5 3 ± 5 5 3 ± 6 5 4 ± 6
Vital capacity (% predicted) S 103±5 107±7 110±9 P 103±4 101±4 9 9 ± 4
Maximal tidal volume (% vital capacity) S 67±6 7 1 ± 5 8 3 ± 3* P 6 4 ± 5 7 2 ± 4 7 0 ± 4 increases in blood pressure to its original value. This is concentration of salbutamol has also been shown to penetrate the blood-brain barrier in rats suggesting that the stimulation accomplished by vagal activation and adrenergic inhibition which decrease heart rate and total peripheral vascular of central b-adrenoceptors may account for some of the drug effects [32] . resistance [9] . When blood pressure is below a targeted level baroreflex sensitivity attenuates preventing furher decrease.
In conclusion, the acute salbutamol inhalation markedly decreases cardiovagal nervous responsiveness, increases symIt was novel to note that the salbutamol dose decreased the LF variability of R-R intervals, which is related to arterial pathetic dominance in the cardiovascular autonomic balance, and has tendency to decrease baroreflex sensitivity. According baroreflex function [7, 9] . The non-significant decrease in baroreflex sensitivity estimated by the cross-spectral analysis to our experience at least some of the undesirable effects are likely to be dependent on the dose kg
. Further studies may be due to the small number of subjects. However, the preservation of baroreflex function correlated positively with are needed to evaluate the effects of b 2 -adrenoceptor agonists on cardiovascular autonomic regulation in adults, because the weight of the test subjects suggesting that attenuation of baroreflex sensitivity may be related to the plasma salbutamol the changes demonstrated in this study are similar to the risks factors known to predipose to malignant ventricular concentrations as the dose was the same. The adverse cardiovascular side-effects depending closely on the drug tachyarrhythmias in adults with heart diseases [33, 34] . dosage were also supported by the negative correlation between the heart rate and the weight of the subjects after
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